Bioequivalence of Eye Drops and Spray Administration of Vigamox
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The study compares the amounts of Vigamox absorbed when administered as eye drops or in a
spray form. Both administrations will be prior to patients undergoing elective cataract
surgery and the aqueous samples will be analyzed by a laboratory in a masked fashion. The
hypothesis is that there will be no difference between the 2 modes of administration.
Phase:
N/A
Details
Lead Sponsor:
Advanced Ophthalmic Pharma
Treatments:
Fluoroquinolones Moxifloxacin Norgestimate, ethinyl estradiol drug combination Ophthalmic Solutions Tetrahydrozoline